Diamond Hill Capital Management Inc. Sells 11,606 Shares of UFP Technologies, Inc. (NASDAQ:UFPT)

Diamond Hill Capital Management Inc. lowered its stake in UFP Technologies, Inc. (NASDAQ:UFPT) by 42.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,664 shares of the industrial products company’s stock after selling 11,606 shares during the period. Diamond Hill Capital Management Inc. owned 0.20% of UFP Technologies worth $4,961,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its holdings in UFP Technologies by 1,614.3% in the first quarter. EverSource Wealth Advisors LLC now owns 120 shares of the industrial products company’s stock valued at $30,000 after acquiring an additional 113 shares in the last quarter. Northwest Investment Counselors LLC bought a new stake in shares of UFP Technologies during the 3rd quarter valued at $32,000. Advisors Asset Management Inc. bought a new stake in shares of UFP Technologies during the 1st quarter valued at $35,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of UFP Technologies during the 2nd quarter valued at $36,000. Finally, GAMMA Investing LLC boosted its holdings in shares of UFP Technologies by 77.9% during the 3rd quarter. GAMMA Investing LLC now owns 137 shares of the industrial products company’s stock valued at $43,000 after buying an additional 60 shares in the last quarter. Institutional investors own 87.28% of the company’s stock.

Insider Transactions at UFP Technologies

In other news, Director Cynthia L. Feldmann sold 647 shares of UFP Technologies stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $352.30, for a total value of $227,938.10. Following the completion of the transaction, the director now owns 4,049 shares of the company’s stock, valued at $1,426,462.70. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other UFP Technologies news, CEO R Jeffrey Bailly sold 10,000 shares of the business’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $325.89, for a total value of $3,258,900.00. Following the completion of the transaction, the chief executive officer now owns 80,044 shares of the company’s stock, valued at approximately $26,085,539.16. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Cynthia L. Feldmann sold 647 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $352.30, for a total value of $227,938.10. Following the completion of the transaction, the director now directly owns 4,049 shares of the company’s stock, valued at approximately $1,426,462.70. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,747 shares of company stock valued at $14,037,015 in the last quarter. 6.17% of the stock is owned by insiders.

UFP Technologies Price Performance

UFPT opened at $343.49 on Tuesday. The stock has a 50-day moving average price of $310.32 and a 200-day moving average price of $292.76. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.56 and a quick ratio of 1.63. The firm has a market cap of $2.63 billion, a PE ratio of 49.00 and a beta of 0.96. UFP Technologies, Inc. has a 1 year low of $140.52 and a 1 year high of $366.41.

Analysts Set New Price Targets

Separately, Lake Street Capital boosted their target price on shares of UFP Technologies from $344.00 to $392.00 and gave the company a “buy” rating in a report on Wednesday, July 17th.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.